Suppr超能文献

[冠心病:中医的创新认识与经方论治]

[Coronary heart disease: innovative understanding from traditional Chinese medicine and treatment by classic formulas].

作者信息

Lan Yu, Luo Fu-Kun, Yu Yue, Wang Xiao-Ya, Wang Peng-Qian, Xiong Xing-Jiang

机构信息

Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2024 Jul;49(13):3684-3692. doi: 10.19540/j.cnki.cjcmm.20240326.501.

Abstract

Coronary heart disease is a common cardiovascular disease, attacking about 11.4 million patients in China. With increasing prevalence and mortality year by year, coronary heart disease has become a major factor threatening human health and public health. Although primary and secondary prevention, intervention, coronary artery bypass grafting and other interventions have reduced the death rate, there are drug(aspirin) resistance, secondary nitroglycerin failure, post-intervention fatigue, chest tightness, and an-xiety, and complication with a high risk of bleeding, which have become the key clinical and scientific issues needed to be resolved. Coronary heart disease belongs to the category of chest impediment and heart pain in traditional Chinese medicine(TCM). The TCM etiology of this disease includes external contraction of cold, emotional disorders, constitutional insufficiency, physical weakness, and labor injury, which are closely related to sympathetic nerve activity, state of cardiac and psychological diseases, family history, and cardiovascular metabolic disorders in modern medicine. The TCM causes of coronary heart disease include Qi depression, phlegm turbidity, blood stasis, fire-heat, cold congealing, and healthy Qi deficiency, which are associated with emotional factors such as anxiety and depression, abnormal lipid metabolism, abnormalities in blood circulation and coagulation, inflammatory responses, hyperactive immune responses, and heart failure, chronic wasting disease, or aging, respectively. Accordingly, the patients with Qi depression should be treated with Chaihu Longgu Muli Decoction, and those with phlegm turbidity should be treated with Wendan Decoction and Gualou Xiebai Banxia Decoction. Xuefu Zhuyu Decoction and Guizhi Fuling Pills are recommended for blood stasis, Xiaoxianxiong Decoction and Sanhuang Xiexin Decoction for fire-heat, Zhishi Xiebai Guizhi Decoction for cold congealing, and Renshen Decoction for healthy Qi deficiency. Due to the changes in the spectrum of diseases from ancient to modern times as well as the differences in physical constitution, the key cause of coronary heart disease has evolved from the chest Yang deficiency and cold congealing to Qi depression, phlegm turbidity, phlegm combined with stasis, and fire-heat, showing a shift from cold to heat and from deficiency to excess. The combination of classic formulas presents a pattern. That is, the core formula-syndrome correspondence of a disease often fixedly appears with other formula-syndrome correspondence, which may be related to the development of the pathophysiological mechanism of the disease. In the clinical application of modern pharmacological results, the research team has formulated the clinical principle of pathogenesis corresponding to pathological changes and medicinal nature corresponding pharmacological effects. The modern pharmacological research on classic formulas is conducive to targeted treatment. Moreover, classic formulas help to ameliorate aspirin resistance, clopidogrel resistance, post-intervention anxiety, and high risk of bleeding and address the lack of effective blockade of critical lesions in the coronary artery and the progression of post-infarction heart failure. The innovative understanding of the etiology and pathogenesis of co-ronary heart disease helps to improve the clinical efficacy of TCM and the clinical system for treating coronary heart disease with classic formulas.

摘要

冠心病是一种常见的心血管疾病,在中国约有1140万患者。随着患病率和死亡率逐年上升,冠心病已成为威胁人类健康和公共卫生的主要因素。尽管一级和二级预防、干预、冠状动脉搭桥术等措施降低了死亡率,但仍存在药物(阿司匹林)抵抗、硝酸甘油继发性失效、干预后疲劳、胸闷、焦虑以及出血风险高等并发症,这些已成为亟待解决的关键临床和科学问题。冠心病在中医中属于胸痹、心痛范畴。本病的中医病因包括外感寒邪、情志失调、体质虚弱、身体亏虚和劳伤,这与现代医学中的交感神经活动、心脏和心理疾病状态、家族史以及心血管代谢紊乱密切相关。冠心病的中医病因包括气滞、痰浊、血瘀、火热、寒凝和正气亏虚,分别与焦虑和抑郁等情绪因素、脂质代谢异常、血液循环和凝血异常、炎症反应、免疫反应亢进以及心力衰竭、慢性消耗性疾病或衰老有关。因此,气滞患者应使用柴胡龙骨牡蛎汤治疗,痰浊患者应使用温胆汤和瓜蒌薤白半夏汤治疗。血瘀推荐用血府逐瘀汤和桂枝茯苓丸,火热用小陷胸汤和三黄泻心汤,寒凝用枳实薤白桂枝汤,正气亏虚用人参汤。由于古今疾病谱的变化以及体质差异,冠心病的关键病因已从胸阳亏虚、寒凝演变为气滞、痰浊、痰瘀互结和火热,呈现出从寒到热、从虚到实的转变。经典方剂的组合呈现出一种模式。也就是说,一种疾病的核心方剂 - 证型对应常常与其他方剂 - 证型对应固定出现,这可能与疾病病理生理机制的发展有关。在现代药理研究成果的临床应用中,研究团队制定了病理变化对应病机、药理作用对应药性的临床原则。对经典方剂的现代药理研究有利于靶向治疗。此外,经典方剂有助于改善阿司匹林抵抗、氯吡格雷抵抗、干预后焦虑以及出血高风险,并解决冠状动脉关键病变缺乏有效阻断以及心肌梗死后心力衰竭进展的问题。对冠心病病因病机的创新性认识有助于提高中医临床疗效以及经典方剂治疗冠心病的临床体系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验